PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases.

Authors :: De Baère, T.
Pracht, M.
Rolland, Y.
Durand-Labrunie, J.
Nguyen, F.
Bronowicki, J.
Vendrely, V.
Cunha, A. Sa
Croisé-Laurent, V.
Rio, E.
Le Sourd, S.
Said, P.
Gustin, P.
Perret, C.
Peiffert, D.
Deutsch, E.
Chajon, E.
Source :: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS74-S75. 2p.
Publication Year :: 2020
Abstract: Poster Highlights: Poster highlights 5 CL: GI PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases T. De BaÃre, M. Pracht, Y. Rolland, J. Durand-Labrunie, F. Nguyen, J. Bronowicki, V. Vendrely, A. Sa Cunha, V. CroisÃ©-Laurent, E. Rio, S. Le Sourd, P. Said, P. Gustin, C. Perret, D. Peiffert, E. Deutsch, E. Chajon. [Extracted from the article]

Full Text Access

Tools